Zhiqiang Liu

发表

Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes

Hong-juan Liu, Tianxiao Zhang, Yili Wang, 2020, Journal of leukocyte biology.

Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2‐mediated chromatin remodelling

Sheng Wang, Gerui Liu, Ying Xie, 2022, Clinical and translational medicine.

Melatonin Enhances Osteoblastogenesis from Senescent Mesenchymal Stem Cells via MMSET Mediated Chromatin Remodeling

Ying Xie, Hui Zhang, Chunhua Liu, 2021 .

Melatonin Enhances Chondrocytes Survival Through Hyaluronic Acid Production and Mitochondria Protection

A. Thapa, Ying Xie, Ziyi Peng, 2021 .

Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor in Multiple Myeloma

Qian Li, Ying Xie, Ya-fei Wang, 2022, Frontiers in Oncology.

DKK1 Activates Non-canonical NF-kB Signaling via IL-6 Induced CKAP4 receptor in Multiple Myeloma.

Ying Xie, Ziyi Peng, Jinxin Zheng, 2021, Blood advances.

DKK1 Suppresses WWP2 to Enhance Bortezomib Resistance in Multiple Myeloma via Regulating GLI2 Ubiquitination.

Bing Chen, Hongyan Wu, Shibiao Xu, 2021, Carcinogenesis.

PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth

J. Kroin, A. V. van Wijnen, H. Im, 2016, Annals of the rheumatic diseases.

Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance

Qian Li, Qiang Wang, Ying Xie, 2021, Nature Communications.

Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma

Sheng Wang, Ying Xie, Xiankui Cheng, 2022, Oncogene.

Leptin correlates with monocytes activation and severe condition in COVID-19 patients

Beizhong Liu, Sheng Wang, Lihua Yu, 2021, Journal of leukocyte biology.

Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma

B. O’Malley, Sheng Wang, Ying Xie, 2021, Nature Communications.

Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma

Beizhong Liu, Sheng Wang, Ying Xie, 2021, Oncogene.

The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells

Lili Qin, Xin Wang, Zhiqiang Liu, 2017, Hematology.

All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma

Sheng Wang, Ying Xie, J. Mi, 2023, Journal for ImmunoTherapy of Cancer.

RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients

Qian Li, Helen J. Huang, G. Karlin-Neumann, 2020, Journal of Cancer.

Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma

Sheng Wang, Ying Xie, Ziyi Peng, 2022, Clinical and translational medicine.

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation

Qiang Wang, Sheng Wang, Ying Xie, 2022, The Journal of clinical investigation.

NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation

Sheng Wang, F. Liu, Ying Xie, 2022, Aging cell.

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome

Hong-juan Liu, Tianxiao Zhang, Yili Wang, 2020, medRxiv.